20 (AIDX) Long-Term Deferred Tax (2024 - 2025)
20 (AIDX) reported Long-Term Deferred Tax of $793100.0 for Q4 2025, down 17.31% on a YoY basis from $959100.0 in Q4 2024, and down 17.31% quarter-over-quarter from $959100.0 in Q4 2024.
20 (AIDX) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends
20 has reported Long-Term Deferred Tax for 2 years, with the latest figure at $793100.0 in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax fell 17.31% year-over-year to $793100.0; the trailing twelve-month figure through Dec 2025 stood at $793100.0 (down 17.31% YoY), and the FY2025 full-year result was $793100.0, down 17.31% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $793100.0, down from $959100.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $959100.0 in Q4 2024, with the low at $793100.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | 20 | - | - | 62,884.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 793,100.00 |
| Dec 31, 2024 | 959,100.00 |